Needham Reiterates Hold on Agilon Healthto Hold
AGLMarch 21, 2025
Read more →Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
AGLJP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and growth in 2025-2027.
March 18, 2025
Read more →CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
AGLFebruary 26, 2025
Read more →RBC Capital Maintains Outperform on Agilon Health, Raises Price Target to $3.5
AGLFebruary 26, 2025
Read more →Citizens Capital Markets Reiterates Market Perform on Agilon Healthto Market Perform
AGLFebruary 26, 2025
Read more →Stifel Maintains Hold on Agilon Health, Raises Price Target to $3
AGLFebruary 26, 2025
Read more →4 Analysts Have This To Say About Agilon Health
AGLFebruary 26, 2025
Read more →Needham Reiterates Hold on Agilon Healthto Hold
AGLFebruary 26, 2025
Read more →Agilon Health Q4 2024 Adj EPS $(0.26) Misses $(0.23) Estimate, Sales $1.52B Inline
AGLFebruary 25, 2025
Read more →Earnings Scheduled For February 25, 2025
AGLFebruary 25, 2025
Read more →Bernstein Maintains Market Perform on Agilon Health, Raises Price Target to $3.15
AGLJanuary 15, 2025
Read more →Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
AGLJanuary 13, 2025
Read more →Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $2.25
AGLJanuary 10, 2025
Read more →Needham Reiterates Hold on Agilon Healthto Hold
AGLJanuary 10, 2025
Read more →RBC Capital Reiterates Outperform on Agilon Health, Maintains $3 Price Target
AGLNovember 19, 2024
Read more →Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
AGLUpgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low of $2.89. Moreover, at the end of the last trading period, the closing price was at $4.26.
September 14, 2022
Read more →RBC Capital Initiates Coverage On Agilon Health with Outperform Rating, Announces Price Target of $33
AGLSeptember 14, 2022
Read more →Where Agilon Health Stands With Analysts
AGLWithin the last quarter, Agilon Health (NYSE:AGL) has observed the following analyst ratings:
September 12, 2022
Read more →4 Analysts Have This to Say About Agilon Health
AGLAnalysts have provided the following ratings for Agilon Health (NYSE:AGL) within the last quarter:
September 12, 2022
Read more →Analyst Ratings for Agilon Health
AGLAnalysts have provided the following ratings for Agilon Health (NYSE:AGL) within the last quarter:
September 12, 2022
Read more →Goldman Sachs Initiates Coverage On Agilon Health with Buy Rating, Announces Price Target of $38
AGLSeptember 12, 2022
Read more →